ECSP10010262A - Polvo nutricional estable - Google Patents
Polvo nutricional estableInfo
- Publication number
- ECSP10010262A ECSP10010262A EC2010010262A ECSP10010262A ECSP10010262A EC SP10010262 A ECSP10010262 A EC SP10010262A EC 2010010262 A EC2010010262 A EC 2010010262A EC SP10010262 A ECSP10010262 A EC SP10010262A EC SP10010262 A ECSP10010262 A EC SP10010262A
- Authority
- EC
- Ecuador
- Prior art keywords
- protein
- hydrolyzed
- weight
- total
- powders
- Prior art date
Links
- 239000000843 powder Substances 0.000 title abstract 5
- 235000016709 nutrition Nutrition 0.000 title abstract 4
- 235000018102 proteins Nutrition 0.000 abstract 5
- 102000004169 proteins and genes Human genes 0.000 abstract 5
- 108090000623 proteins and genes Proteins 0.000 abstract 5
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 abstract 2
- 102000011632 Caseins Human genes 0.000 abstract 2
- 108010076119 Caseins Proteins 0.000 abstract 2
- 239000000787 lecithin Substances 0.000 abstract 2
- 229940067606 lecithin Drugs 0.000 abstract 2
- 235000010445 lecithin Nutrition 0.000 abstract 2
- 150000002632 lipids Chemical class 0.000 abstract 2
- 230000001953 sensory effect Effects 0.000 abstract 2
- 108010046377 Whey Proteins Proteins 0.000 abstract 1
- 102000007544 Whey Proteins Human genes 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 235000014633 carbohydrates Nutrition 0.000 abstract 1
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 235000013350 formula milk Nutrition 0.000 abstract 1
- 230000007062 hydrolysis Effects 0.000 abstract 1
- 238000006460 hydrolysis reaction Methods 0.000 abstract 1
- 238000010348 incorporation Methods 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 230000001590 oxidative effect Effects 0.000 abstract 1
- 230000002195 synergetic effect Effects 0.000 abstract 1
- 235000021119 whey protein Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/10—Foods or foodstuffs containing additives; Preparation or treatment thereof containing emulsifiers
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Dairy Products (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Una incorporación del invento está dirigida a polvos nutricionales, inclusive polvos para formulas infantiles, que incluyen carbohidratos; lípidos que incluyen alrededor de 0.25% a alrededor de 2.5% de lecitina por peso del total de lípidos; de alrededor de 90% a alrededor de 99.5% de proteína intacta por peso del total de proteína; y de alrededor de 0.5% a alrededor de 10% de al menos una proteína hidrolizada seleccionada del grupo que incluye proteína caseína hidrolizada y proteína hidrolizada de suero, por peso del total de proteína; en que la proteína hidrolizada tiene un grado de hidrólisis de entre alrededor de 23% y alrededor de 90%. Se ha encontrado, sorprendentemente, que las incorporaciones del polvo nutricional del presente invento presentan una estabilidad oxidativa mejorada y mejorado rendimiento sensorial. Se encontró que los niveles seleccionados de proteína caseína hidrolizada en combinación con la lecitina proporcionan un efecto antioxidante sinérgico, y por lo tanto pueden ser formuladas dentro de los polvos nutricionales para reducir la oxidación y proporcionar un mejor rendimiento sensorial por periodos prolongados.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1531807P | 2007-12-20 | 2007-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP10010262A true ECSP10010262A (es) | 2010-07-30 |
Family
ID=40788959
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EC2010010262A ECSP10010262A (es) | 2007-12-20 | 2010-06-16 | Polvo nutricional estable |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US8377496B2 (es) |
| EP (1) | EP2242382B1 (es) |
| JP (1) | JP2011507518A (es) |
| CN (1) | CN101951789B (es) |
| AR (1) | AR070679A1 (es) |
| AU (1) | AU2008343689A1 (es) |
| BR (1) | BRPI0820584A2 (es) |
| CA (1) | CA2708527C (es) |
| CL (1) | CL2008003809A1 (es) |
| CO (1) | CO6280447A2 (es) |
| CR (1) | CR11508A (es) |
| DO (1) | DOP2010000176A (es) |
| EC (1) | ECSP10010262A (es) |
| GT (1) | GT201000173A (es) |
| IL (1) | IL206132A (es) |
| MX (1) | MX2010006887A (es) |
| MY (1) | MY168206A (es) |
| NZ (1) | NZ585619A (es) |
| PA (1) | PA8808701A1 (es) |
| PE (1) | PE20091332A1 (es) |
| RU (1) | RU2481008C2 (es) |
| SV (1) | SV2010003599A (es) |
| TW (1) | TWI418307B (es) |
| WO (1) | WO2009085388A2 (es) |
| ZA (1) | ZA201003912B (es) |
Families Citing this family (56)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2470340T3 (es) | 2005-12-28 | 2014-06-23 | Advanced Bionutrition Corporation | Vehículo de administración para bacterias probi�ticas que comprende una matriz seca de polisac�ridos, sac�ridos y polioles en forma vítrea |
| WO2008076975A1 (en) | 2006-12-18 | 2008-06-26 | Advanced Bionutrition Corporation | A dry food product containing live probiotic |
| WO2009126932A2 (en) * | 2008-04-10 | 2009-10-15 | Provide Nutrition | Fortified liquid protein compositions and methods of making same |
| EP3266448B1 (en) | 2009-03-27 | 2022-02-16 | Intervet International B.V. | Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish |
| NZ720946A (en) | 2009-04-29 | 2017-09-29 | Amarin Pharmaceuticals Ie Ltd | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
| MX350088B (es) | 2009-04-29 | 2017-08-25 | Amarin Pharma Inc | Composicion farmaceutica estable y metodos de uso de la misma. |
| AU2010254235B2 (en) | 2009-05-26 | 2015-04-02 | Advanced Bionutrition Corporation | Stable dry powder composition comprising biologically active microorganisms and/or bioactive materials and methods of making |
| CN108096209A (zh) | 2009-06-15 | 2018-06-01 | 阿马里纳制药公司 | 在相伴他汀类疗法的对象中降低甘油三酯、没有增加ldl-c水平的组合物和方法 |
| TW201112967A (en) * | 2009-09-16 | 2011-04-16 | Abbott Lab | Dryblended nutritional powders |
| US20110071176A1 (en) | 2009-09-23 | 2011-03-24 | Amarin Pharma, Inc. | Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same |
| US9504750B2 (en) | 2010-01-28 | 2016-11-29 | Advanced Bionutrition Corporation | Stabilizing composition for biological materials |
| BR112012018839B1 (pt) | 2010-01-28 | 2020-04-14 | Advanced Bionutrition Corp | composição vítrea seca compreendendo um material bioativo |
| US8840950B2 (en) * | 2010-05-26 | 2014-09-23 | Jacqueline M. Hibbert | Compositions of nutrition supplementation for nutritional deficiencies and method of use therefore |
| MX350047B (es) | 2010-08-13 | 2017-08-24 | Advanced Bionutrition Corp | Composicion de estabilizacion de almacenamiento en seco para materiales biologicos. |
| NZ712068A (en) | 2010-11-29 | 2017-03-31 | Amarin Pharmaceuticals Ie Ltd | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
| US11712429B2 (en) | 2010-11-29 | 2023-08-01 | Amarin Pharmaceuticals Ireland Limited | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
| CN102599402B (zh) * | 2011-01-25 | 2013-09-04 | 光明乳业股份有限公司 | 一种乳清蛋白组合物及其制备方法 |
| EP2672843B1 (en) * | 2011-02-07 | 2018-07-11 | Abbott Laboratories | Nutritional products comprising beta-hydroxy-beta-methylbutyrate |
| CN102273520B (zh) * | 2011-08-02 | 2013-08-07 | 中国科学院新疆理化技术研究所 | 乳清营养粉及其制备方法 |
| US20130089638A1 (en) * | 2011-10-11 | 2013-04-11 | Mead Johnson Nutrition Company | Compositions Comprising Maltotriose And Methods Of Using Same To Inhibit Damage Caused By Dehydration Processes |
| WO2013056038A2 (en) * | 2011-10-14 | 2013-04-18 | Abbott Laboratories | Sterilized liquid protein supplement |
| US11291643B2 (en) | 2011-11-07 | 2022-04-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
| US20130131170A1 (en) | 2011-11-07 | 2013-05-23 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
| ES2891473T3 (es) | 2012-01-06 | 2022-01-28 | Amarin Pharmaceuticals Ie Ltd | Composiciones y métodos para reducir los niveles de alta sensibilidad (hs-CRP) en un sujeto |
| BR112014023234B1 (pt) * | 2012-03-23 | 2020-12-08 | Advanced Bionutrition Corporation | composição de estabilização seca em um estado vítreo amorfo para um material bioativo, método para produzir a referida composição e produtos preparados com a mesma |
| CA3067012C (en) | 2012-06-29 | 2021-10-05 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of a cardiovascular event in a subject on statin therapy |
| WO2014074552A2 (en) | 2012-11-06 | 2014-05-15 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy |
| US20140187633A1 (en) | 2012-12-31 | 2014-07-03 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis |
| US9452151B2 (en) | 2013-02-06 | 2016-09-27 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing apolipoprotein C-III |
| US9624492B2 (en) | 2013-02-13 | 2017-04-18 | Amarin Pharmaceuticals Ireland Limited | Compositions comprising eicosapentaenoic acid and mipomersen and methods of use thereof |
| US20140271841A1 (en) | 2013-03-15 | 2014-09-18 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin |
| US20140328970A1 (en) * | 2013-05-03 | 2014-11-06 | Mead Johnson Nutrition Company | Nutritional Composition Comprising Whey and Hydrolyzed Casein and Uses Thereof |
| US10966968B2 (en) | 2013-06-06 | 2021-04-06 | Amarin Pharmaceuticals Ireland Limited | Co-administration of rosiglitazone and eicosapentaenoic acid or a derivative thereof |
| US20150065572A1 (en) | 2013-09-04 | 2015-03-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing prostate cancer |
| US9585859B2 (en) | 2013-10-10 | 2017-03-07 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy |
| US10639334B2 (en) * | 2014-01-07 | 2020-05-05 | Mead Johnson Nutrition Company | Pediatric nutritional composition with milk peptides for healthy growth and development |
| US10561631B2 (en) | 2014-06-11 | 2020-02-18 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing RLP-C |
| US10172818B2 (en) | 2014-06-16 | 2019-01-08 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids |
| WO2016014514A1 (en) * | 2014-07-21 | 2016-01-28 | Abbott Laboratories | Nutritional powder with polyunsaturated fatty acid and improved organoleptic properties |
| CN106659223A (zh) * | 2014-07-21 | 2017-05-10 | 雅培制药有限公司 | 具有特定抗氧化剂的营养粉末 |
| CN107205448A (zh) * | 2015-01-16 | 2017-09-26 | 威尔君克斯有限公司 | 含胶原蛋白和附加添加剂的饮料 |
| US12558395B2 (en) | 2015-07-29 | 2026-02-24 | Advanced Bionutrition Corp. | Stable dry probiotic compositions for special dietary uses |
| EP3328215B1 (en) | 2015-07-29 | 2021-07-07 | Advanced BioNutrition Corp. | Stable dry probiotic compositions for special dietary uses |
| EP3362061B1 (en) * | 2015-10-15 | 2023-09-06 | N.V. Nutricia | Infant formula with milk fat for promoting healthy growth |
| WO2017117121A1 (en) | 2015-12-28 | 2017-07-06 | Abbott Laboratories | Nutritional compositions comprising hydrolyzed protein and a modified fat system and uses thereof |
| CN108471797A (zh) * | 2016-02-05 | 2018-08-31 | 雅培制药有限公司 | 基于乳清蛋白的液体营养组合物 |
| US10406130B2 (en) | 2016-03-15 | 2019-09-10 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids |
| WO2018213663A1 (en) | 2017-05-19 | 2018-11-22 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject having reduced kidney function |
| US11197917B2 (en) | 2017-12-01 | 2021-12-14 | ByHeart, Inc. | Formulations for nutritional support in subjects in need thereof |
| US11058661B2 (en) | 2018-03-02 | 2021-07-13 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides in a subject on concomitant statin therapy and having hsCRP levels of at least about 2 mg/L |
| MA51766A (fr) | 2018-09-24 | 2020-12-16 | Amarin Pharmaceuticals Ie Ltd | Procédés de réduction du risque d'événements cardiovasculaires chez un sujet |
| KR20220050084A (ko) * | 2019-02-21 | 2022-04-22 | 인제뉴어티 푸즈 인코포레이티드 | 식품의 영양 강화를 위한 콜린 및 오메가-3 지방산을 포함하는 조성물 |
| BR112022009189A2 (pt) | 2019-11-12 | 2022-07-26 | Amarin Pharmaceuticals Ie Ltd | Métodos para reduzir o risco de eventos cardiovasculares em um sujeito com fibrilação atrial e/ou palpitação atrial |
| US11986452B2 (en) | 2021-04-21 | 2024-05-21 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing the risk of heart failure |
| CN113632993A (zh) * | 2021-08-24 | 2021-11-12 | 黑龙江八一农垦大学 | 黑豆-乳清双蛋白运动营养粉 |
| CN116965483A (zh) * | 2023-07-21 | 2023-10-31 | 广州白云山汉方现代药业有限公司 | 一种氧化稳定性好的蛋黄磷脂组合物及应用 |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5024849A (en) | 1990-05-01 | 1991-06-18 | Nestec S.A. | Liquid coffee whitener |
| US5021245A (en) * | 1990-05-22 | 1991-06-04 | Abbott Laboratories | Infant formula containing a soy polysaccharide fiber source |
| CA2089920C (en) | 1992-02-21 | 1999-06-15 | John D. Johnston | Synergistic compositions for extending animal feed shelf life |
| NL9300848A (nl) | 1993-05-14 | 1994-12-01 | Friesland Frico Domo Coop | Werkwijze voor de bereiding van lang houdbare melkconcentraten en melkpoeders. |
| US5405637A (en) | 1993-06-30 | 1995-04-11 | Bristol-Myers Squibb Company | Milk protein partial hydrolysate and infant formula containing same |
| US6136858A (en) * | 1994-01-10 | 2000-10-24 | Abbott Laboratories | Infant formula and methods of improving infant stool patterns |
| EP0739207B1 (en) * | 1994-01-10 | 2008-10-01 | Abbott Laboratories | Enteral formula with ribo-nucleotides |
| US5635199A (en) | 1995-10-27 | 1997-06-03 | Nestec Ltd. | Support of pediatric patients |
| HUP0300236A3 (en) * | 1997-02-21 | 2003-09-29 | Univ Tennessee Res Corp Knoxvi | Use of polyunsaturated fatty acids for reducing the incidence of necrotizing enterocolitis and process for their preparation |
| EP1034704A1 (en) * | 1999-03-12 | 2000-09-13 | Societe Des Produits Nestle S.A. | Nutritional composition intended for specific gastro-intestinal maturation in premature mammals |
| US6294206B1 (en) | 1999-04-09 | 2001-09-25 | Abbott Laboratories | Powdered human milk fortifier |
| US6365218B1 (en) * | 2000-02-04 | 2002-04-02 | Abbott Laboratories | Pediatric formula and methods for providing nutrition and improving tolerance |
| US6207638B1 (en) * | 2000-02-23 | 2001-03-27 | Pacifichealth Laboratories, Inc. | Nutritional intervention composition for enhancing and extending satiety |
| ATE369045T1 (de) * | 2001-11-26 | 2007-08-15 | Nestec Sa | Lagerstabiles nahrungsmittelprodukt enthaltend molkenprotein, verfahren zu seiner herstellung und verwendung |
| RU2262867C2 (ru) * | 2002-02-14 | 2005-10-27 | Катков Юрий Адольфович | Бад к пище для улучшения репродукции человека (варианты) |
| US7070825B2 (en) | 2002-09-10 | 2006-07-04 | Abbott Laboratories | Infant formula |
| TWI317636B (en) | 2002-11-22 | 2009-12-01 | Meiji Dairies Corp | Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress |
| WO2005089255A2 (en) | 2004-03-12 | 2005-09-29 | Nellson Northern Operating Inc. | Novel protein layering masses, processes for the manufacture thereof, and related products |
| CA2537647A1 (en) | 2005-03-01 | 2006-09-01 | Six Star Formulations Ltd. | Supplemental dietary composition for supporting muscle growth, recovery and strength |
| US20060233915A1 (en) | 2005-04-15 | 2006-10-19 | Bristol-Myers Squibb Company | Liquid nutritional product to supplement human milk |
| US7618669B2 (en) | 2005-06-01 | 2009-11-17 | Mead Johnson Nutrition Company | Low-lactose partially hydrolyzed infant formula |
| DE102005031468A1 (de) | 2005-07-04 | 2007-01-18 | Basf Ag | Wässrige Suspensionen schwer wasserlöslicher oder wasserunlöslicher Wirkstoffe und daraus hergestellte Trockenpulver |
| CA2646672A1 (en) | 2006-03-23 | 2007-09-27 | Nestec S.A. | High-calorie nutritional supplement |
| ATE524073T1 (de) | 2006-03-27 | 2011-09-15 | Nestec Sa | Molkenprotein micellen |
| US7875303B2 (en) | 2006-03-31 | 2011-01-25 | Kraft Foods Global Brands Llc | Protein system and food products including same |
| US20070281054A1 (en) * | 2006-05-31 | 2007-12-06 | Abbott Laboratories | Organic powder nutritional formula containing select carbohydrate combinations |
| WO2010047581A1 (en) | 2008-10-24 | 2010-04-29 | N.V. Nutricia | Liquid high-fat protein composition |
-
2008
- 2008-10-29 MY MYPI2010002838A patent/MY168206A/en unknown
- 2008-10-29 RU RU2010129984/13A patent/RU2481008C2/ru not_active IP Right Cessation
- 2008-10-29 NZ NZ585619A patent/NZ585619A/en unknown
- 2008-10-29 MX MX2010006887A patent/MX2010006887A/es active IP Right Grant
- 2008-10-29 US US12/260,320 patent/US8377496B2/en active Active
- 2008-10-29 CN CN200880121364.8A patent/CN101951789B/zh not_active Expired - Fee Related
- 2008-10-29 JP JP2010539546A patent/JP2011507518A/ja active Pending
- 2008-10-29 EP EP08869051.6A patent/EP2242382B1/en not_active Revoked
- 2008-10-29 BR BRPI0820584-1A patent/BRPI0820584A2/pt not_active Application Discontinuation
- 2008-10-29 AU AU2008343689A patent/AU2008343689A1/en not_active Abandoned
- 2008-10-29 WO PCT/US2008/081596 patent/WO2009085388A2/en not_active Ceased
- 2008-10-29 CA CA2708527A patent/CA2708527C/en active Active
- 2008-11-26 TW TW097145733A patent/TWI418307B/zh not_active IP Right Cessation
- 2008-12-17 PE PE2008002092A patent/PE20091332A1/es not_active Application Discontinuation
- 2008-12-18 PA PA20088808701A patent/PA8808701A1/es unknown
- 2008-12-18 CL CL2008003809A patent/CL2008003809A1/es unknown
- 2008-12-19 AR ARP080105554A patent/AR070679A1/es not_active Application Discontinuation
-
2010
- 2010-05-31 CO CO10065329A patent/CO6280447A2/es not_active Application Discontinuation
- 2010-06-01 IL IL206132A patent/IL206132A/en active IP Right Grant
- 2010-06-01 ZA ZA2010/03912A patent/ZA201003912B/en unknown
- 2010-06-11 DO DO2010000176A patent/DOP2010000176A/es unknown
- 2010-06-15 GT GT201000173A patent/GT201000173A/es unknown
- 2010-06-16 EC EC2010010262A patent/ECSP10010262A/es unknown
- 2010-06-17 CR CR11508A patent/CR11508A/es not_active Application Discontinuation
- 2010-06-18 SV SV2010003599A patent/SV2010003599A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CR11508A (es) | 2011-08-12 |
| TWI418307B (zh) | 2013-12-11 |
| MX2010006887A (es) | 2010-10-15 |
| TW200932128A (en) | 2009-08-01 |
| MY168206A (en) | 2018-10-15 |
| PA8808701A1 (es) | 2009-07-23 |
| NZ585619A (en) | 2012-06-29 |
| CL2008003809A1 (es) | 2009-10-16 |
| JP2011507518A (ja) | 2011-03-10 |
| AU2008343689A1 (en) | 2009-07-09 |
| CO6280447A2 (es) | 2011-05-20 |
| CA2708527A1 (en) | 2009-07-09 |
| AR070679A1 (es) | 2010-04-28 |
| BRPI0820584A2 (pt) | 2015-07-14 |
| IL206132A0 (en) | 2010-11-30 |
| WO2009085388A2 (en) | 2009-07-09 |
| IL206132A (en) | 2014-04-30 |
| CN101951789B (zh) | 2014-02-05 |
| US20090162518A1 (en) | 2009-06-25 |
| EP2242382B1 (en) | 2016-11-16 |
| ZA201003912B (en) | 2011-06-29 |
| WO2009085388A3 (en) | 2010-09-02 |
| RU2481008C2 (ru) | 2013-05-10 |
| CN101951789A (zh) | 2011-01-19 |
| US8377496B2 (en) | 2013-02-19 |
| CA2708527C (en) | 2016-06-14 |
| DOP2010000176A (es) | 2010-10-15 |
| PE20091332A1 (es) | 2009-09-30 |
| RU2010129984A (ru) | 2012-01-27 |
| EP2242382A2 (en) | 2010-10-27 |
| GT201000173A (es) | 2012-04-03 |
| SV2010003599A (es) | 2011-01-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ECSP10010261A (es) | Polvo nutricional estable | |
| AR070679A1 (es) | Polvo nutricional estable | |
| AR097110A1 (es) | Composiciones nutricionales que contienen una combinación sinérgica y usos de las mismas | |
| MX2018001117A (es) | Composiciones nutricionales con 2fl y lnnt para usar en la induccion de una microbiota intestinal cercana a la de los infantes alimentados por lactancia materna. | |
| BR112015017322A2 (pt) | composição flavorizante e composições comestíveis contendo a mesma | |
| EA201070419A1 (ru) | Состав для регулирования метаболизма липидов | |
| CO6561822A2 (es) | Emulsiones nutricionales que comprenden hmb de calcio y proteinas soluble | |
| BR112014017469A8 (pt) | produto de confeitaria congelado de baixa proteína | |
| BR112013027474A2 (pt) | composições que melhoram a palatabilidade | |
| MA39157A1 (fr) | Composition utile pour favoriser la fertilite feminine | |
| EA201070967A1 (ru) | Улучшенные ароматизированные кондитерские продукты | |
| BR112012023328A2 (pt) | composições nutricionais | |
| MX382069B (es) | Composiciones que comprenden 2fl y lnnt para controlar la ingesta de alimento y el crecimiento en infantes o niños pequeños. | |
| MX2016001635A (es) | Probiotico para el llanto infantil excesivo. | |
| ECSP13012807A (es) | Composición que comprende proteínas de leche termolábiles y proceso para para preparar la misma | |
| MX374579B (es) | Composiciones sinteticas de la leche que comprenden acidos grasos poliinsaturados (pufa) para promover el establecimiento saludable de la funcion congnitiva en los infantes de ambos generos, niños y niñas. | |
| MX2013004371A (es) | Cisteina y consumo de alimentos. | |
| MX374580B (es) | Composiciones de leche sintetica que comprenden acido eicosatrienoico n-6 y lipidos polares para infantes menores y mayores de tres meses para el establecimiento saludable de la funcion cognitiva. | |
| ATE463169T1 (de) | Nährkonzentrat für kleinkinder | |
| MX2017007952A (es) | Nutricion infantil con proteina hidrolizada, calcio ionico y acido palmitico. | |
| PH12015502727A1 (en) | Methods and compositions for enhancing cognitive performance | |
| ATE382267T1 (de) | Organoleptisch verbesserte und besonders lagerstabile hartkaramellen | |
| MX2015011388A (es) | Induccion de una respuesta inmunitaria de proteccion en recien nacidos y lactantes por una unica dosis elevada de mva. | |
| BR112018009381A8 (pt) | suplemento alimentar compreendendo beta-glucano e hidrolisado de caseína para melhora da saúde e desempenho de crescimento em um mamífero | |
| DK2040558T3 (da) | Mejeriproduktbaseret næringsmiddel indeholdende centralnervesystem-lipider |